Intraoperative Mitomycin C Versus Intraoperative 5-Fluorouracil for Trabeculectomy: A Systematic Review and Meta-Analysis

被引:21
|
作者
Lin, Zhong-Jie [1 ]
Li, You [1 ,2 ]
Cheng, Jin-Wei [1 ]
Lu, Xiao-He [2 ]
机构
[1] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Ophthalmol, Shanghai 200003, Peoples R China
[2] So Med Univ, Zhujiang Hosp, Dept Ophthalmol, Guangzhou 515282, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
INITIAL TRABECULECTOMY; GLAUCOMA; SUBCONJUNCTIVAL; FLUOROURACIL; SURGERY;
D O I
10.1089/jop.2011.0117
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The aim of this study was to assess the intraoperative application of mitomycin C (MMC) compared to 5-fluorouracil (5-FU) on the outcome of trabeculectomy and to examine the balance of risk and benefit. Methods: Pertinent studies were selected through systematic searches of major literature databases, including the Cochrane Library, PubMed, Embase, and Chinese Biomedicine Database. Internet searches of search engines, the professional associations' websites, and the manufacturers' databases were also performed. Clinical controlled trials comparing 5-FU with MMC in trabeculectomy were selected. The primary efficacy measure was the weighted mean difference (WMD) in percentage intraocular pressure reduction (IOPR%) at follow-up end point. The secondary efficacy measure was the relative risk (RR) for "qualified'' (with or without medical therapy) success of trabeculectomy at follow-up end point. The third efficacy measure was RR for "complete'' (without medical therapy) success of trabeculectomy at follow-up end point. The fourth efficacy measure was RR for adverse events, including wound leak, hypotony, endophalmitis, and shallow anterior chamber (AC). The pooled effects were calculated using the random effects model by RevMan version 5.0 software. Results: Eight studies enrolling a total of 536 patients were included in the meta-analysis. MMC was associated with significantly more IOPR% compared with 5-FU, with a WMD of 7.09 [95% confidence interval (CI) 1.47-12.70] at follow-up end point (P = 0.01). MMC was comparable with 5-FU in qualified success rate, with a RR of 1.09 (0.99-1.20) at follow-up end point (P = 0.09). MMC was comparable with 5-FU in complete success rate, with a RR of 1.17 (0.79-1.75) at follow-up end point (P = 0.43). Rates of adverse events did not differ significantly between 5-FU and MMC, with an RR of 0.71 (0.22-2.28) for bleb leakage, 1.40 (0.72-2.72) for hypotony, 1.63 (0.27-9.75) for endophthalmitis, and 0.95 (0.41-2.21) for shallow AC. Conclusions: Intraoperative MMC is more effective in lowering IOP in trabeculectomy compared with intraoperative 5-FU, but is comparable with intraoperative 5-FU in both qualified and complete success rate. Intraoperative use of both agents may contribute equally to adverse events.
引用
收藏
页码:166 / 173
页数:8
相关论文
共 50 条
  • [1] Trabeculectomy with intraoperative 5-fluorouracil vs mitomycin C
    Singh, K
    Egbert, PR
    Byrd, S
    Budenz, DL
    Williams, AS
    Decker, JH
    Dadzie, P
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (01) : 48 - 53
  • [2] Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil -: Prospective randomized clinical trial
    Singh, K
    Mehta, K
    Shaikh, NM
    Tsai, JC
    Moster, MR
    Budenz, DL
    Greenfield, DS
    Chen, PP
    Cohen, JS
    Baerveldt, GS
    Shaikh, S
    [J]. OPHTHALMOLOGY, 2000, 107 (12) : 2305 - 2309
  • [3] Long-term Outcomes of Intraoperative 5-Fluorouracil versus Intraoperative Mitomycin C in Primary Trabeculectomy Surgery
    Palanca-Capistrano, Angelita M.
    Hall, Jason
    Cantor, Louis B.
    Morgan, Lincki
    Hoop, Joni
    WuDunn, Darrell
    [J]. OPHTHALMOLOGY, 2009, 116 (02) : 185 - 190
  • [4] Comparison of intraoperative 5-fluorouracil versus mitomycin C at six and twelve months in primary trabeculectomy
    Finley, C
    Cantor, LB
    WuDunn, D
    Hoop, JS
    Lakhani, VK
    Alvi, NP
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S967 - S967
  • [5] Trabeculectomy with intraoperative 5-fluorouracil
    Sidoti, PA
    Choi, JC
    Morinelli, EN
    Lee, PP
    Baerveldt, G
    Minckler, DS
    Heuer, DK
    [J]. OPHTHALMIC SURGERY AND LASERS, 1998, 29 (07): : 552 - 561
  • [6] Efficacy and safety of intraoperative injection of mitomycin C during trabeculectomy: a systematic review and meta-analysis
    Zheng, Jing
    Zhang, Ai
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2024, 44 (01)
  • [7] Intermediate-term outcomes for primary trabeculectomy with intraoperative 5-fluorouracil versus mitomycin
    Fish, RI
    Capistrano, AP
    Dunn, DW
    Cantor, L
    Hoop, J
    Finley, C
    Lakhani, V
    Alvi, N
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U435 - U435
  • [8] TRABECULECTOMY IN PSEUDOPHAKIC PATIENTS - POSTOPERATIVE 5-FLUOROURACIL VERSUS INTRAOPERATIVE MITOMYCIN-C ANTIPROLIFERATIVE THERAPY
    PRATA, JA
    MINCKLER, DS
    BAERVELDT, G
    LEE, PP
    LABREE, L
    HEUER, DK
    [J]. OPHTHALMIC SURGERY AND LASERS, 1995, 26 (01): : 73 - 77
  • [9] Topical intraoperative 5-fluorouracil in trabeculectomy
    RodriguezSalvador, V
    Salinas, E
    Illueca, A
    Vilela, C
    Vila, E
    Avino, JA
    Menezo, JL
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 2581 - 2581
  • [10] Trabeculectomy with intraoperative sponge 5-fluorouracil
    Mora, JS
    Nguyen, N
    Iwach, AG
    Gaffney, MM
    Hetherington, J
    Hoskins, HD
    Wong, PC
    Tran, H
    Dickens, CJ
    [J]. OPHTHALMOLOGY, 1996, 103 (06) : 963 - 970